サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1756406

CRISPR-Cas遺伝子の世界市場：製品種類別・技術別・送達方法別・治療領域別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

CRISPR And Cas Genes Market, By Product Type, By Technology, By Delivery Method, By Therapeutic Area, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
CRISPR-Cas遺伝子の世界市場：製品種類別・技術別・送達方法別・治療領域別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年05月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

CRISPR-Cas遺伝子市場規模は2024年に47億129万米ドルとなり、2025年から2032年にかけてCAGR 16.50%で拡大

CRISPR-Cas遺伝子の市場力学

精密遺伝子編集の進歩が市場成長を加速

特にCRISPR-Cas遺伝子を含む精密遺伝子編集技術の進歩は、世界中で研究と治療への応用を大幅に加速させています。米国国立衛生研究所（NIH）によると、遺伝子編集臨床試験の70％以上が、その精度と効率性から現在CRISPR-Casシステムに焦点を当てています。米国食品医薬品局（FDA）は最近、これらのツールを利用した遺伝子治療をいくつか承認したが、これは規制当局の受け入れが進んでいることを反映しています。さらに、ヒトゲノム計画のような世界のイニシアチブは、遺伝性疾患の理解を拡大し続け、精密な遺伝子編集ソリューションへの需要を煽っています。しかし、オフターゲット効果や倫理的配慮といった課題は依然として残っており、安全性と送達を改善する技術革新の機会が開かれています。これらの進歩は、精密遺伝子編集が複雑な遺伝性疾患に対処し、個別化医療を進める上で極めて重要な役割を果たすダイナミックな状況を醸成しています。

CRISPR-Cas遺伝子市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約16.50％のCAGRで毎年成長すると予測されています。

製品種類別では、製品が2024年に最大市場シェアを示すと予測されています。

技術に基づくと、2024年にはCRISPR/Cas9が主要技術でした。

送達方法別では、ウイルスベクターが2024年の主要デリバリー方法でした。

治療領域別では、2024年にはがん領域が主要な治療領域となっています。

エンドユーザー別では、2024年の主要エンドユーザーはバイオテクノロジー・製薬企業でした。

地域別では、北米が2024年の主要収益源です。

CRISPR-Cas遺伝子市場：セグメンテーション分析

世界のCRISPR-Cas遺伝子市場は、製品種類、技術、送達方法、治療領域、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品種類に基づいて2つのカテゴリーに分けられます。製品（キット・試薬、ライブラリー）、サービス（微生物遺伝子編集、細胞株エンジニアリング、gRNA設計・合成、DNA合成、スクリーニングサービス、その他）です。製品セグメントは、Casタンパク質やガイドRNAを含むキット＆試薬がリードし、デザインツールや抗体を特徴とするライブラリーが続きます。サービスは、微生物遺伝子編集、細胞株工学、gRNA設計、DNA合成、スクリーニングに重点を置き、包括的な遺伝子編集ワークフローを世界にサポートしています。

市場は技術によって3つのカテゴリーに分けられます。CRISPR/Cas9、CRISPR/Cas12、CRISPR/Cas13、その他。CRISPR/Cas9は精密な遺伝子編集用途で優位を占め、診断や治療薬に使用されるCRISPR/Cas12がこれに続きます。CRISPR/Cas13はRNAターゲティングに特化し、その他には世界中の研究および臨床の場で能力を拡大する新興の変異体が含まれます。

CRISPR-Cas遺伝子市場：地域別分析

CRISPR-Cas遺伝子市場は、強固な研究インフラと政府支援に牽引され、北米、欧州、アジア太平洋全域で力強い活動を示しています。北米は、米国国立衛生研究所（National Institutes of Health）のような機関からの多額の資金援助と、ボストンやサンフランシスコのような主要なバイオテクノロジー・ハブの存在によってリードしています。欧州は、ドイツ、英国、フランスなどの国々が、欧州連合のホライズンプログラムの支援を受けて遺伝子編集研究を進めています。アジア太平洋は、特に中国、日本、韓国で急成長しており、バイオテクノロジーへの投資が増加し、規制の枠組みが技術革新と商業化を促進しています。ラテンアメリカや中東の新興市場では、ヘルスケアや農業用途に遺伝子編集技術の導入が始まっているが、そのペースは緩やかです。CRISPR-Cas遺伝子の世界の足跡は、世界の共同作業と学術的パートナーシップによってさらに強化されつつあり、市場の発展における地域の専門知識とリソースの重要性が浮き彫りになっています。

CRISPR-Cas遺伝子市場：競合情勢

CRISPR-Cas遺伝子市場の競合情勢は、遺伝子編集技術の発展に注力する主要バイオテクノロジー企業、学術機関、革新的新興企業によって形成されています。Editas Medicine社、CRISPR Therapeutics社、Intellia Therapeutics社などの大手企業は、独自のCRISPR-Casプラットフォームを積極的に開発しており、戦略的提携やライセンス契約によって技術力を拡大しています。学術研究センターは、新たなCas変異体の発見や送達方法の改善によって大きく貢献し、技術革新に拍車をかけています。また、塩基編集やプライム編集などのニッチ技術を持つ新興企業も出現しており、精度を高め、オフターゲット効果を低減しています。知的財産権は重要な役割を担っており、現在進行中の特許紛争は競争力学に影響を及ぼしています。製薬会社や研究機関との提携は、治療法の開発と商業化の努力を加速させる。さらに、スケーラブルな生産とバイオインフォマティクスツールの改良のための研究開発への投資が競争を激化させています。

目次

第1章 CRISPR-Cas遺伝子市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 CRISPR-Cas遺伝子の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 CRISPR-Cas遺伝子市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 CRISPR-Cas遺伝子市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 CRISPR-Cas遺伝子の市場情勢

  • CRISPR-Cas遺伝子の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 CRISPR-Cas遺伝子市場：製品種類別

  • 概要
    • セグメント別シェア分析：製品種類別
    • 製品
      • キット・試薬
      • Casタンパク質・酵素
      • ガイドRNA
      • その他
      • ライブラリー
      • デザインツール
      • 抗体
      • その他
    • サービス
      • 微生物遺伝子編集
      • 細胞株エンジニアリング
      • gRNAの設計・合成
      • DNA合成
      • スクリーニングサービス
      • その他

第8章 CRISPR-Cas遺伝子市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • CRISPR/Cas9
    • CRISPR/Cas12
    • CRISPR/Cas13
    • その他

第9章 CRISPR-Cas遺伝子市場：送達方法別

  • 概要
    • セグメント別シェア分析：送達方法別
    • 物理的方法（エレクトロポレーション、マイクロインジェクション）
    • ウイルスベクター
    • 非ウイルスベクター

第10章 CRISPR-Cas遺伝子市場：治療領域別

  • 概要
    • セグメント別シェア分析：治療領域別
    • 腫瘍学
    • 遺伝性疾患
    • 感染症
    • その他

第11章 CRISPR-Cas遺伝子市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • バイオテクノロジー・製薬会社
    • 学術機関、政府研究機関
    • CRO（医薬品開発業務受託機関）

第12章 CRISPR-Cas遺伝子市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析：CRISPR-Cas遺伝子業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Addgene
    • Beam Therapeutics
    • Caribou Biosciences
    • CRISPR Therapeutics AG
    • Editas Medicine
    • GenScript Biotech Corporation
    • Horizon Discovery Group
    • Integrated DNA Technologies（IDT）
    • Intellia Therapeutics
    • Mammoth Biosciences
    • Merck KGaA（Sigma-Aldrich）
    • New England Biolabs
    • Precision BioSciences
    • Synthego Corporation
    • Thermo Fisher Scientific
    • ToolGen Inc.
    • Others

第14章 AnalystViewの全方位的分析

目次
Product Code: ANV5305

REPORT HIGHLIGHT

CRISPR And Cas Genes Market size was valued at US$ 4,701.29 Million in 2024, expanding at a CAGR of 16.50% from 2025 to 2032.

The CRISPR and Cas Genes Market involves advanced gene-editing technologies used for precise genetic modifications across research, therapeutic, and agricultural applications. Increasing adoption of gene-editing tools for developing personalized medicine and disease-resistant crops boosts innovation, while challenges like ethical concerns and regulatory hurdles limit rapid growth. Growing investments in genetic research have led to a surge in CRISPR patent filings, with over 3,000 patents recorded by major institutions globally. Opportunities lie in expanding applications in rare genetic disorders and regenerative medicine, supported by initiatives from organizations like the National Institutes of Health (NIH), promoting genome editing research. However, complexities in delivery methods and off-target effects pose restraints, underscoring the need for improved accuracy and safety in gene-editing practices.

CRISPR And Cas Genes Market- Market Dynamics

Advancements in Precision Gene Editing to Accelerate Market Growth

Advancements in precision gene editing technologies, particularly involving CRISPR and Cas genes, are significantly accelerating research and therapeutic applications worldwide. According to the National Institutes of Health (NIH), over 70% of gene-editing clinical trials currently focus on CRISPR-Cas systems due to their accuracy and efficiency. The U.S. Food and Drug Administration (FDA) has recently approved several gene therapies utilizing these tools, reflecting growing regulatory acceptance. Furthermore, global initiatives like the Human Genome Project continue to expand understanding of genetic diseases, fueling demand for precise gene-editing solutions. However, challenges such as off-target effects and ethical considerations persist, opening opportunities for innovations that improve safety and delivery. These advancements are fostering a dynamic landscape where precision gene editing plays a pivotal role in addressing complex genetic disorders and advancing personalized medicine.

CRISPR And Cas Genes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.50% over the forecast period (2025-2032)

Based on product type segmentation, the Product was predicted to show maximum market share in the year 2024

Based on Technology segmentation, CRISPR/Cas9 was the leading Technology in 2024

Based on Delivery Method segmentation, Viral Vectors were the leading Delivery Method in 2024

Based on Therapeutic Area segmentation, Oncology was the leading Therapeutic Area in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

CRISPR And Cas Genes Market- Segmentation Analysis:

The Global CRISPR and Cas Genes Market is segmented on the basis of Product Type, Technology, Delivery Method, Therapeutic Area, End User, and Region.

The market is divided into two categories based on product type: Product (Kits & Reagents and Libraries), and Service (Microbial Gene Editing, Cell Line Engineering, gRNA Design & Synthesis, DNA Synthesis, Screening Services, and Others). Product segment leads with Kits & Reagents, including Cas Proteins and Guide RNA, followed by Libraries featuring design tools and antibodies. Services focus on microbial gene editing, cell line engineering, gRNA design, DNA synthesis, and screening, supporting comprehensive gene-editing workflows globally.

The market is divided into three categories based on Technology: CRISPR/Cas9, CRISPR/Cas12, CRISPR/Cas13, and Others. CRISPR/Cas9 dominates with precise gene editing applications, followed by CRISPR/Cas12 used in diagnostics and therapeutics. CRISPR/Cas13 specializes in RNA targeting, while others include emerging variants expanding capabilities across research and clinical settings worldwide.

CRISPR And Cas Genes Market- Geographical Insights

The CRISPR and Cas Genes market shows strong activity across North America, Europe, and Asia-Pacific, driven by robust research infrastructure and government support. North America leads due to substantial funding from agencies like the National Institutes of Health and the presence of leading biotech hubs such as Boston and San Francisco. Europe follows closely, with countries like Germany, the UK, and France advancing gene-editing research through initiatives supported by the European Union's Horizon programs. Asia-Pacific is rapidly growing, especially in China, Japan, and South Korea, where increasing investments in biotechnology and supportive regulatory frameworks are fostering innovation and commercialization. Emerging markets in Latin America and the Middle East are beginning to adopt gene-editing technologies for healthcare and agricultural applications, although at a slower pace. Collaborative efforts and academic partnerships worldwide are further strengthening the global footprint of CRISPR and Cas genes, highlighting the importance of regional expertise and resource availability in advancing the market.

CRISPR And Cas Genes Market- Competitive Landscape:

The competitive landscape of the CRISPR and Cas Genes market is shaped by key biotechnology companies, academic institutions, and innovative startups focusing on advancing gene-editing technologies. Major players such as Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics are actively developing proprietary CRISPR-Cas platforms, with strategic collaborations and licensing agreements expanding their technological capabilities. Academic research centers contribute significantly by discovering new Cas variants and improving delivery methods, fueling innovation. Startups are also emerging with niche technologies, including base editing and prime editing, enhancing precision and reducing off-target effects. Intellectual property rights play a critical role, with ongoing patent disputes influencing competitive dynamics. Partnerships with pharmaceutical companies and research organizations accelerate therapeutic development and commercialization efforts. Additionally, investment in R&D for scalable production and improved bioinformatics tools is intensifying competition, as firms strive to meet growing demand across therapeutic and agricultural applications globally.

Recent Developments:

In November 2024, Vertex and CRISPR Therapeutics received authorization for the world's first CRISPR/Cas9-based gene editing therapy, CASGEVY, for sickle cell disease and transfusion-dependent beta thalassemia, marking a major milestone in the clinical application of CRISPR and Cas gene technologies.

In August 2024, CRISPR QC launched three innovative products-RNP Formation, DNA Target Binding, and CLEAVE-within its CRISPR Analytics Platform, offering real-time insights into CRISPR/Cas gene editing workflows. These tools optimize efficiency, accuracy, and quality control for gene editing research and therapeutic development.

In January 2025, Researchers at Aarhus University unveiled a triple-action CRISPR technology enabling simultaneous gene activation, repression, and deletion in primary human T cells. This breakthrough uses multiple CRISPR/Cas systems, advancing complex genetic engineering for cell therapy and regenerative medicine applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR AND CAS GENES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Addgene
  • Beam Therapeutics
  • Caribou Biosciences
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript Biotech Corporation
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Intellia Therapeutics
  • Mammoth Biosciences
  • Merck KGaA (Sigma-Aldrich)
  • New England Biolabs
  • Precision BioSciences
  • Synthego Corporation
  • Thermo Fisher Scientific
  • ToolGen Inc.
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Product
  • Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
  • Libraries
  • Design Tool
  • Antibodies
  • Others
  • Service
  • Microbial Gene Editing
  • Cell Line Engineering
  • gRNA Design & Synthesis
  • DNA Synthesis
  • Screening Services
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • CRISPR/Cas9
  • CRISPR/Cas12
  • CRISPR/Cas13
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Physical Methods (Electroporation, Microinjection)
  • Viral Vectors
  • Non-Viral Vectors

GLOBAL CRISPR AND CAS GENES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL CRISPR AND CAS GENES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology & Pharmaceutical Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL CRISPR AND CAS GENES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CRISPR And Cas Genes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CRISPR And Cas Genes Market Snippet by Product Type
    • 2.1.2. CRISPR And Cas Genes Market Snippet by Technology
    • 2.1.3. CRISPR And Cas Genes Market Snippet by Delivery Method
    • 2.1.4. CRISPR And Cas Genes Market Snippet by Therapeutic Area
    • 2.1.5. CRISPR And Cas Genes Market Snippet by End User
    • 2.1.6. CRISPR And Cas Genes Market Snippet by Country
    • 2.1.7. CRISPR And Cas Genes Market Snippet by Region
  • 2.2. Competitive Insights

3. CRISPR And Cas Genes Key Market Trends

  • 3.1. CRISPR And Cas Genes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CRISPR And Cas Genes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CRISPR And Cas Genes Market Opportunities
  • 3.4. CRISPR And Cas Genes Market Future Trends

4. CRISPR And Cas Genes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CRISPR And Cas Genes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. CRISPR And Cas Genes Market Landscape

  • 6.1. CRISPR And Cas Genes Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CRISPR And Cas Genes Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Product
      • 7.1.2.1. Kits & Reagents
      • 7.1.2.1.1. Cas Proteins & Enzymes
      • 7.1.2.1.2. Guide RNA
      • 7.1.2.1.3. Others
      • 7.1.2.2. Libraries
      • 7.1.2.2.1. Design Tool
      • 7.1.2.2.2. Antibodies
      • 7.1.2.2.3. Others
    • 7.1.3. Service
      • 7.1.3.1. Microbial Gene Editing
      • 7.1.3.2. Cell Line Engineering
      • 7.1.3.3. gRNA Design & Synthesis
      • 7.1.3.4. DNA Synthesis
      • 7.1.3.5. Screening Services
      • 7.1.3.6. Others

8. CRISPR And Cas Genes Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. CRISPR/Cas9
    • 8.1.3. CRISPR/Cas12
    • 8.1.4. CRISPR/Cas13
    • 8.1.5. Others

9. CRISPR And Cas Genes Market - By Delivery Method

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 9.1.2. Physical Methods (Electroporation, Microinjection)
    • 9.1.3. Viral Vectors
    • 9.1.4. Non-Viral Vectors

10. CRISPR And Cas Genes Market - By Therapeutic Area

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 10.1.2. Oncology
    • 10.1.3. Genetic Disorders
    • 10.1.4. Infectious Diseases
    • 10.1.5. Others

11. CRISPR And Cas Genes Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Biotechnology & Pharmaceutical Companies
    • 11.1.3. Academic & Government Research Institutes
    • 11.1.4. Contract Research Organizations (CROs)

12. CRISPR And Cas Genes Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. CRISPR And Cas Genes Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. CRISPR And Cas Genes Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. CRISPR And Cas Genes Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. CRISPR And Cas Genes Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. CRISPR And Cas Genes Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- CRISPR And Cas Genes Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Addgene
    • 13.2.2. Beam Therapeutics
    • 13.2.3. Caribou Biosciences
    • 13.2.4. CRISPR Therapeutics AG
    • 13.2.5. Editas Medicine
    • 13.2.6. GenScript Biotech Corporation
    • 13.2.7. Horizon Discovery Group
    • 13.2.8. Integrated DNA Technologies (IDT)
    • 13.2.9. Intellia Therapeutics
    • 13.2.10. Mammoth Biosciences
    • 13.2.11. Merck KGaA (Sigma-Aldrich)
    • 13.2.12. New England Biolabs
    • 13.2.13. Precision BioSciences
    • 13.2.14. Synthego Corporation
    • 13.2.15. Thermo Fisher Scientific
    • 13.2.16. ToolGen Inc.
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us